Tesla (NASDAQ:TSLA) may see its core EV business facing some challenges, but its lofty valuation reflects confidence in future game-changers like

Goldman Sachs updates its view on Tesla FSD, says 'Tesla's Robotaxi business to begin commercial operations in 2H 2026' with remote assistance, geofencing.

Shares in Tesla Inc. ( TSLA, Financial) fell near 3% in Thursday's morning trading, while Goldman Sachs reaffirmed its Neutral rating and kept the stock's price target at $345.

Wedbush Securities increased its price target on Tesla (NASDAQ:TSLA) shares to $550, up from the previous $515. The firm continues to recommend an Outperform rating for the electric vehicle manufacturer.

Tesla FSD and robotaxi opportunities are highlighted by an analyst in a new report with robotaxi revenue estimates for 2027 listed.

Goldman Sachs' credit-card partnership with Apple may end before its contract runs out in 2030, Goldman CEO David Solomon said on Wednesday.

In a report released yesterday, Mark Delaney from Goldman Sachs maintained a Hold rating on Tesla (TSLA – Research Report), with a price target

On Thursday, Goldman Sachs reaffirmed its Neutral rating on Tesla stock (NASDAQ:TSLA) with a steady price target of $345.00. According to InvestingPro data, analyst targets for Tesla currently ...

On Thursday, Goldman Sachs (NYSE:GS) reaffirmed its Neutral rating on Tesla stock (NASDAQ:TSLA) with a steady price target of $345.00. According to InvestingPro data, analyst targets for Tesla currently range from $120 to $528, with the stock trading at a ...

Bank of New York Mellon, BlackRock, and Goldman Sachs were among the financial firms posting better-than-expected earnings. Tesla shares gained as Barclays analysts raised their price target for the stock based on the electric vehicle maker's work on ...

Han Zheng is scheduled to attend the celebrations in Washington D.C. on Monday and is the most senior Chinese official to attend a U.S. inauguration.

U.S. stock indexes drifted lower following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies